ISRCTN17473023进行中（未招募）未知
Colorectal Cancer Cohort Study (COLO-COHORT)
South Tyneside and Sunderland NHS Foundation Trust0 个研究点目标入组 15,000 人开始时间: 2019年12月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Aged =30 years and able to give informed consent
- •2. Patients attending colonoscopy:
- •2.1 Through Bowel Cancer Screening Programme (FIT positive, Bowelscope conversion, surveillance)
- •2.2 Through standard NHS care (most commonly due to iron deficiency anaemia, altered bowel habit, weight loss, rectal bleeding, planned polypectomy, those referred on basis of family history, abnormal cross-sectional imaging, polyp surveillance or post CRC surveillance)
- •(COLO-SPEED) Group B:
- •1. Any patient attending for colonoscopy and able to give informed consent
- •2. At least 18 years old
- •3. In a centre supported by COLO-SPEED infrastructure (i.e. in North of England)
排除标准
- •1. Unable to give informed consent
- •2. Known polyposis syndrome
- •3. Previous total colectomy
- •4. Known colonic stricture which would limit complete colonoscopy
- •5. Attending for planned therapeutic procedure other than polypectomy, such as insertion of colonic stent
- •6. Attending for assessment of known inflammatory bowel disease (IBD) activity or for IBD surveillance
- •7. Patients currently recruited into an interventional CTIMP for CRC prevention
- •COLO-SPEED (Group B):
- •1. DOes not meet inclusion criteria
研究者
相似试验
招募中
不适用
COLON-study Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that influence colorectal tumour recurrence, survival and quality of life10017991colorectal cancerNL-OMON32845Wageningen Universiteit1,000
已完成
不适用
Vitamin C for Colorectal Cancer: A clinical window study to assess high dose vitamin C administration in colorectal cancer patientsCancer - Bowel - Back passage (rectum) or large bowel (colon)Colorectal cancerACTRN12615001277538Prof Margreet Vissers12
招募中
Unknown
Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors, CRC-DR studycolorectal cancerJPRN-UMIN000051316Kyoto Prefectural University of Medicine1,000
进行中（未招募）
1 期
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
尚未招募
不适用
Evaluation of Colorectal neoplasia(s) incidence in Bariatric Surgery Candidatescolorectal neoplasiascreening colonoscopyDiet and Nutrition - ObesityCancer - Bowel - Back passage (rectum) or large bowel (colon)colorectal cancerObesityACTRN12620000120976Mehmet Ali Yerdel200